Skip to main content
Premium Trial:

Request an Annual Quote

Rob Ashley, David Cohen, Michael Cusanovich, Gordon Goodyear, Saundra Johnson, Rob Kennedy, Edward Koeneman, Loretta Mayer, Christine McAuliffe, Jon McGarity, Michael Mobley, Jacqueline Nicol, Nina Ossanna, Thomas Rainey, Debbie Snyder, Diane Williamson

The Arizona BioIndustry Association has restructured its operations to “better support the growth and success of its member companies and to unify, empower, and advance the bioscience industry” throughout the state, AZBio said this week.
As part of the restructuring, AZBio has integrated with the Bioindustry Organization of Southern Arizona, and a new board of directors has been selected to lead the association.
The following individuals comprise the new board:
  • Rob Ashley, Ashley BioPharm, Tucson
  • David Cohen, Can-Am Pharmaceutical Services, Tucson
  • Michael Cusanovich, Arizona Research Labs, University of Arizona, Tucson
  • Gordon Goodyear, 3d Biosurfaces, Tucson
  • Saundra Johnson, The Flinn Foundation, Phoenix
  • Rob Kennedy, Apthera, Scottsdale
  • Edward Koeneman, Kinetic Muscles, Tempe
  • Loretta Mayer, Senestech, Flagstaff
  • Christine McAuliffe, Jennings Strouss & Salmon, Phoenix
  • Jon McGarity, InSys Therapeutics, Phoenix
  • Michael Mobley, Biodesign Institute, Arizona State University, Tempe
  • Jacqueline Nicol, BioVigilant, Tucson
  • Nina Ossanna, BIO5 Institute, University of Arizona, Tucson
  • Thomas Rainey, Northern Arizona Center for Emerging Technologies, Flagstaff
  • Debbie Snyder, TGen Drug Development Services, Scottsdale
  • Diane Williamson, Earth Friendly Fuels, Flagstaff